Elfabrio (pegunigalsidase alfa-iwxj) - Protalix, Chiesi
GoPEG: German Observational Multicenter Study of Patients With Fabry Disease Under Enzyme Replacement Therapy With Pegunigalsidase-alfa (clinicaltrials.gov) - May 1, 2026 - P=N/A | N=60 | Active, not recruiting | Sponsor: Universität Münster | Recruiting ➔ Active, not recruiting 
Enrollment closed • Fabry Disease • Genetic Disorders
http://clinicaltrials.gov/ct2/show/NCT06095713
 
May 1, 2026
 
Prev Next